Long-circulating and targeting synergistic multifunctional anti-tumor targeting nano-drug carrier
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- NANKAI UNIV
- Publication Date
- 2014-09-24
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine and nanomedicine, in particular to a multifunctional anti-tumor targeting nano drug carrier with long circulation and targeting synergy. Background technique
[0002] Cancer is a malignant disease that affects human health. In the past three decades, the incidence of cancer in the world has increased at a rate of 3-5% per year, seriously endangering people's physical and mental health. The current treatment strategy for tumors is a combination of chemotherapy, surgical resection, radiotherapy and biological therapy. Among them, drug chemotherapy is one of the main means of treating tumors. The anti-tumor chemotherapy drugs used are still mainly small molecule cytotoxic drugs, and these drugs are widely distributed in the body after administration. At the same time, the vast majority of anti-tumor drugs are hydrophobic, and few of them can reach tumor tissues after intravenous administration, ...